Project Overview

Building on its 2004 study of the Burden of Skin Disease, the Society for Investigative Dermatology (SID) has launched a new initiative to determine the Burden of Skin Disease Co-Morbidities. In recent years, there has been increasing evidence linking various skin diseases with a number of co-morbid conditions, some of which occur as a consequence of treatment for severe skin disease.

Overall Co-Morbidities Project Purpose

The multi-year, multi component project is designed to facilitate interaction and collaboration across multiple medical disciplines and fields, in order to

• identify the depth and state of knowledge on connections between dermatologic and non-dermatologic diseases, including their existence, scientific basis and prevalence;
• make recommendations pertaining to support of basic and clinical research in the area; and
• enhance public (including media and policy) awareness and public and policy support for basic and clinical research in the area.

Sponsors

• Abbott
• Amgen
• Centocor, Inc.
• OSI Pharmaceuticals